Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949819 · ClinicalTrials.gov registry record
Active Surveillance for Cancer of the Prostate (ASCaP)
A clinical trial of Prostate Cancer, sponsored by Jonsson Comprehensive Cancer Center.
- Recruiting
- Registry status
- 462
- Enrollment target
- 1
- Study location
NCT00949819 is a study of Prostate Cancer that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 462 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00949819, a study of Prostate Cancer, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 462 participants
- Enrollment target
- 1
- Study location
Study Summary
Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.
Conditions Studied
Interventions
- OTHER Active surveillance
Study Locations (1)
California
- University of California Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 462 participants |
| Start Date | 2009-07-04 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00949819
The ClinicalTrials.gov registry entry for NCT00949819 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 462 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (24% lower). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Active surveillance is the first listed.
NCT00949819 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00949819 about?
NCT00949819 is a clinical study titled "Active Surveillance for Cancer of the Prostate (ASCaP)". Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progress...
What is the current status of trial NCT00949819?
This trial is currently recruiting. The enrollment target is 462 participants. The study started on 2009-07-04. Estimated completion is 2028-12.
What conditions does trial NCT00949819 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00949819?
The interventions under investigation include: Active surveillance (OTHER).
Who is sponsoring clinical trial NCT00949819?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00949819 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.